Latest / Becker’s Healthcare Podcast / Advancing Cardiovascular Innovation Through Research and Culture with Dr. Mark J. Ricciardi

Transcript

Advancing Cardiovascular Innovation Through Research and Culture with Dr. Mark J. Ricciardi · Becker’s Healthcare Podcast

• 0:02
  - There's a small circle of people who truly
• 0:04
  - understand what it takes to lead a health
• 0:05
  - system right now. The decisions are enormous.
• 0:08
  - The variables are constantly shifting, and the stakes
• 0:11
  - of getting a call wrong don't stay contained.
• 0:14
  - That's not a complaint. It's a structural reality.
• 0:17
  - And it's why the most effective c suite
• 0:19
  - leaders are deliberate about where they go to
• 0:21
  - pressure test their thinking.
• 0:22
  - Becker's fourteenth annual CEO and CFO roundtable
• 0:26
  - brings together more than 1,500
• 0:28
  - executive level attendees
• 0:30
  - and nearly 400 speakers for four days built
• 0:32
  - around growth, financial sustainability,
• 0:35
  - workforce strategy, and the leadership questions that don't
• 0:38
  - have easy answers.
• 0:39
  - Join us November second through the fifth in
• 0:41
  - Chicago.
• 0:42
  - For the agenda and event details,
• 0:45
  - visit beckershospitalreview.com
• 0:47
  - and click on the events tab in the
• 0:49
  - upper right.
• 0:50
  - Welcome to the Becker's Healthcare Cardiology and Heart
• 0:53
  - Surgery podcast.
• 0:54
  - I'm Mariah Taylor, assistant editor, and I'm thrilled
• 0:57
  - to be speaking with Mark Ricciardi,
• 0:59
  - section chief for interventional cardiology and structural heart
• 1:01
  - disease at Endeavor Health. Thank you so much
• 1:04
  - for joining me today. I'm really excited to
• 1:06
  - learn more about your cardiovascular
• 1:08
  - innovation.
• 1:09
  - But before we dive into all my questions,
• 1:11
  - I'd love for you to introduce yourself and
• 1:13
  - tell us a little bit about your background.
• 1:14
  - Okay. Great. Thanks, Mara.
• 1:16
  - As you mentioned, I'm section chief for interventional
• 1:18
  - cardiology
• 1:19
  - and structural heart disease. I focus a lot
• 1:22
  - of my attention on heart valve disease,
• 1:25
  - mainly invasive approaches to,
• 1:27
  - repairing and replacing heart valves.
• 1:30
  - I'm at Endeavor Health, which is on, the
• 1:32
  - Northern Suburb of Chicago,
• 1:34
  - formerly known as, NorthShore.
• 1:37
  - And we oversee a pretty large group, a
• 1:39
  - busy group of clinicians and researchers up here.
• 1:43
  - I've been with Endeavor North Shore for about
• 1:46
  - five years. Prior to that, I was, Downtown
• 1:48
  - Chicago at, one of the institutions down there.
• 1:51
  - Originally a New Yorker,
• 1:53
  - moved to the Chicago land area
• 1:55
  - many years ago,
• 1:57
  - about twenty five years ago,
• 1:59
  - but I've main maintained some of my allegiances,
• 2:01
  - at least to New York sports, but, otherwise,
• 2:03
  - full on Chicagoan.
• 2:05
  - Excellent. Well, it's so great to have you.
• 2:08
  - And if our listeners don't know, Endeavor Health
• 2:11
  - recently ranked in the top 10 nationally for
• 2:13
  - innovations in interventional cardiovascular medicine, which is so
• 2:17
  - exciting. Congratulations to you guys.
• 2:19
  - I'd love to hear what are some of
• 2:21
  - those innovations that helped you earn that earn
• 2:24
  - that recognition?
• 2:25
  - Yeah.
• 2:26
  - Okay. Well, I,
• 2:28
  - sort of I think it's a sort of
• 2:30
  - threefold answer maybe. I think first and terribly
• 2:34
  - important for institutions
• 2:35
  - is, you know, what your history is and
• 2:38
  - all. And one of the reasons I was
• 2:39
  - attracted to this particular,
• 2:41
  - health system is because,
• 2:43
  - although we've only been here, for five years,
• 2:45
  - we've really doubled down on our section's history
• 2:48
  - of embracing new tech device therapies,
• 2:52
  - which have always been geared toward the patients
• 2:53
  - in greatest need. So way back in twenty
• 2:55
  - o three,
• 2:58
  - our system was the very first to do
• 3:00
  - a mitral valve repair through a catheter in
• 3:02
  - the leg, a MitraClip procedure,
• 3:05
  - in The US and the second in the
• 3:06
  - world. And that, in my,
• 3:09
  - way of viewing things, that's really what started
• 3:11
  - this,
• 3:12
  - our embracing new tech in, the cardiovascular
• 3:15
  - realm. And then just a few years later,
• 3:17
  - we're one of the first centers in the
• 3:18
  - country to really participate,
• 3:21
  - in what to be proved to be a
• 3:23
  - real revolution in heart care, and that's TAVR,
• 3:25
  - transcatheter
• 3:26
  - valve
• 3:27
  - replacement
• 3:28
  - for the treatment of aortic stenosis.
• 3:31
  - And then so we've simply extended that effort,
• 3:34
  - in the current era by performing some of
• 3:36
  - the regions first, now tricuspid
• 3:38
  - repairs,
• 3:39
  - some of the regions first mitral valve therapies,
• 3:42
  - whether investigation or new tech,
• 3:44
  - new techniques,
• 3:46
  - mostly meant to mitigate some of the risks
• 3:49
  - of valve,
• 3:50
  - therapies.
• 3:51
  - So we've really embraced our past, I think,
• 3:53
  - is or shall we answer that? Second,
• 3:55
  - we've really worked hard to revamp our approach
• 3:58
  - to participation
• 4:00
  - in early feasibility trials and the large pivotal
• 4:02
  - trials that are meant to ultimately lead to
• 4:05
  - commercial
• 4:06
  - commercialization
• 4:07
  - of some of these new devices. And by
• 4:09
  - setting an expectation locally that we're gonna be
• 4:11
  - a top enroller in these clinical trials,
• 4:14
  - Our health system now plays a more meaningful
• 4:16
  - role when it comes to device development,
• 4:18
  - keeps us in the game. And when it
• 4:20
  - comes to partnering,
• 4:22
  - with those bringing these new technologies,
• 4:25
  - we now are an active participant. And I
• 4:28
  - would say third
• 4:29
  - and maybe one of the reasons we got
• 4:31
  - some recent,
• 4:32
  - recognitions, we created an outcomes research group within
• 4:36
  - our Cardiovascular
• 4:37
  - Institute.
• 4:38
  - And this, research group gathers
• 4:41
  - and analyzes data and publishes our findings
• 4:44
  - as a way to better understand the determinants
• 4:46
  - of clinical outcomes.
• 4:48
  - These findings have been presented at some of
• 4:50
  - the most distinguished cardiovascular conferences, including
• 4:53
  - TCT where we got this recognition.
• 4:56
  - You know, as you alluded to, we were
• 4:58
  - ranked number six in The US, number nine
• 5:01
  - globally for our research efforts.
• 5:03
  - And, you know, more broadly, we have a
• 5:05
  - very productive group here. Our cardiovascular fellows
• 5:09
  - and research faculty,
• 5:11
  - published a ton in the last couple years.
• 5:12
  - We have participated in,
• 5:14
  - over 90 clinical trials at this point. Many
• 5:17
  - of our faculty even though we're not a
• 5:20
  - pure
• 5:21
  - university
• 5:22
  - center, we're really an academic center, non university
• 5:25
  - center. But many of our, faculty function as
• 5:28
  - research mentors,
• 5:29
  - and we've really been represented in every major
• 5:32
  - cardiology conference, including American College of Cardiology,
• 5:36
  - ESE, TCT,
• 5:37
  - goes on and on. And so we're proud
• 5:40
  - of that.
• 5:41
  - Absolutely. That is a incredible history of innovation.
• 5:45
  - I'd love to know a little bit more
• 5:46
  - about what was one of your top performing
• 5:49
  - innovations, and what have some of those results
• 5:51
  - been?
• 5:52
  - Yeah. So, you know, I I would say
• 5:54
  - that I don't have a single, like, innovation,
• 5:57
  - a single device that's gone mainstream. But what
• 5:59
  - I'm probably most proud of participating in is
• 6:02
  - our work in the tricuspid valve space,
• 6:05
  - where we really help to find therapies for
• 6:08
  - patients who literally,
• 6:10
  - no exaggeration, had no treatment options outside of
• 6:13
  - diuretic therapy. And these patients were facing the
• 6:16
  - prospect of very poor quality of life and
• 6:18
  - and premature death. And because of these efforts
• 6:21
  - in this space,
• 6:23
  - by
• 6:24
  - institutions, not just ours but ones like ours,
• 6:26
  - we're seeing a real seismic shift in the
• 6:29
  - care of patients with severe tricuspid valve disease
• 6:32
  - through new repair and replacement
• 6:34
  - devices
• 6:35
  - that are all performed minimally invasively. These are
• 6:37
  - patients who would
• 6:39
  - really in no way be able to tolerate
• 6:40
  - open heart surgery. So that's I think that's
• 6:43
  - the the current innovation that it has been
• 6:45
  - the most jazzed and the most,
• 6:48
  - engaged.
• 6:49
  - Absolutely.
• 6:50
  - Now here at Becker's, I personally cover a
• 6:53
  - lot of different beats, but I don't feel
• 6:54
  - like anyone is innovating quite like cardiovascular
• 6:57
  - medicine. There's constantly new changes, new procedures, new
• 7:00
  - devices, and which makes it so fun and
• 7:02
  - exciting.
• 7:03
  - But on the other side of things, I'd
• 7:05
  - love your opinion on what aspects of cardiovascular
• 7:08
  - medicine do you believe have been overlooked for
• 7:10
  - innovation?
• 7:11
  - Yeah. Well, that's a tough one. It's like
• 7:13
  - you mentioned, there is so much innovation going
• 7:15
  - on in the cardiovascular
• 7:17
  - space.
• 7:18
  - Certainly in my particular space within cardiovascular medicine,
• 7:21
  - which is interventional and structural heart valve interventions.
• 7:24
  - But
• 7:25
  - I so I'll focus on that. And I
• 7:26
  - think
• 7:28
  - while we are experiencing our an incredible boom
• 7:30
  - and innovation for new device therapies,
• 7:33
  - Many of these therapies have been studied and
• 7:35
  - introduced into clinical
• 7:37
  - care's clinical care's really niche
• 7:39
  - therapies for just
• 7:40
  - really, really high risk and frail
• 7:43
  - patients who couldn't otherwise,
• 7:45
  - with SANSA and open heart
• 7:47
  - surgery,
• 7:48
  - to treat their valve. So my opinion,
• 7:52
  - you know, a true patient centered approach to
• 7:54
  - minimally invasive therapies
• 7:55
  - should not really be beholden to
• 7:58
  - an open heart surgical precedent, if you will,
• 8:01
  - but should look to expand the application of
• 8:03
  - these really ingenious therapies to a broader patient
• 8:06
  - population, not those just at the end of
• 8:08
  - their ropes at if you will. So I
• 8:10
  - think that's one area that I think
• 8:13
  - maybe we're overlooking and maybe in my view,
• 8:15
  - anyway, we should be more aggressive about broadening
• 8:19
  - who we are targeting to care for and
• 8:21
  - not maybe just the most
• 8:23
  - frail and end of the line,
• 8:25
  - patients, but those who maybe deserve more treatment
• 8:28
  - options, especially minimal invasive ones.
• 8:31
  - Excellent.
• 8:32
  - Now my last question for you is giving
• 8:35
  - advice to other leaders. I've talked to a
• 8:37
  - lot of different people over the last few
• 8:39
  - years, and many leaders, particularly in cardiology, are
• 8:42
  - looking to innovate at their facility. They're trying
• 8:44
  - to open new programs, new procedures. Right? They're
• 8:47
  - hungry for more. And as someone who is
• 8:50
  - already there, you're at the top of innovation,
• 8:52
  - you're doing all the incredible stuff, kind of
• 8:54
  - where they want to be.
• 8:56
  - What advice do you have for them on
• 8:58
  - a first step they could take this month
• 9:00
  - to really bring more innovation to their hospitals?
• 9:03
  - Yeah. Okay.
• 9:04
  - Well, this month okay. Well, first, I would
• 9:07
  - say
• 9:08
  - to these leaders,
• 9:10
  - to support, reward those in their system who
• 9:13
  - really passionately
• 9:15
  - and selflessly
• 9:16
  - work to bring innovation and clinical research to
• 9:18
  - the practice.
• 9:20
  - I think all
• 9:21
  - institutions,
• 9:22
  - have these people,
• 9:24
  - who really do are passionate about it or
• 9:27
  - selfless about it and doing this for the
• 9:29
  - right reasons.
• 9:30
  - And so that might be the first step
• 9:32
  - is to identify people within
• 9:34
  - and, quote, support them. But I think more
• 9:37
  - broadly,
• 9:38
  - it's it's to create a culture. You know?
• 9:41
  - So I started,
• 9:42
  - talking to Mariah about the history here, and
• 9:45
  - and so it's a little easier to build
• 9:47
  - on a culture that's already there. But I
• 9:49
  - think in a way, you gotta you gotta
• 9:51
  - build a culture. So these hospitals and leaders,
• 9:54
  - in my opinion, we need to view themselves
• 9:56
  - not just as me too providers of care,
• 9:59
  - you know, doing what others can do, but
• 10:01
  - create a system and maybe groups of talented
• 10:03
  - physicians and investigators who can deliver care that
• 10:06
  - is special and unique.
• 10:09
  - And then by doing that, you know, need
• 10:10
  - to prioritize innovation and clinical research through
• 10:14
  - investment, of course, and and treatment research and
• 10:17
  - innovation efforts, you know, with the same focus
• 10:20
  - that we have on clinical care. You know,
• 10:21
  - clinical care, we focus so much on efficiencies
• 10:24
  - and,
• 10:25
  - demonstrating quality
• 10:27
  - and always getting better. And, but
• 10:31
  - maybe focusing
• 10:32
  - similar efforts on on, research and innovation would
• 10:35
  - be very helpful. So doing high quality clinical
• 10:38
  - research that explores better ways to treat our
• 10:40
  - patients
• 10:41
  - shouldn't really be viewed as, well, we'll get
• 10:43
  - around to that when we get a chance,
• 10:45
  - but we really gotta focus on the clinical
• 10:47
  - stuff right now. I think they have to
• 10:48
  - be done in parallel,
• 10:50
  - and that the research and innovation has to
• 10:52
  - be
• 10:54
  - considered integral to the way these systems approach
• 10:56
  - their roles in the medical community. So I
• 10:58
  - think
• 10:59
  - there's just a ton of great medical centers
• 11:02
  - out there, provide great care. They're efficient,
• 11:05
  - responsive to patients' needs and all that stuff.
• 11:07
  - But
• 11:08
  - I think if you fold in
• 11:11
  - research and innovation and make that integral to
• 11:14
  - how,
• 11:15
  - these places see themselves in their larger medical
• 11:18
  - communities, I think that's that creating that culture
• 11:20
  - is a it's a big lift, but I
• 11:22
  - think it's a really important one to get
• 11:24
  - started on early.
• 11:26
  - Excellent. That is some great advice, and this
• 11:28
  - has been such a great discussion. Thank you
• 11:30
  - so much for joining me on the podcast
• 11:31
  - today. Alright. Thank you very much.